Agenus Inc (NASDAQ: AGEN)’s stock price has gone rise by 7.46 in comparison to its previous close of 14.12, however, the company has experienced a 4.21% increase in its stock price over the last five trading days. businesswire.com reported 2024-06-28 that LEXINGTON, Mass.–(BUSINESS WIRE)–Agenus Inc. (“Agenus”) (Nasdaq: AGEN), a leader in developing novel immunological agents to treat various cancers, today announced results from an investigator-sponsored trial (IST) of botensilimab and balstilimab (BOT/BAL) in the neoadjuvant setting for colon cancer. Data were presented at the 2024 European Society for Medical Oncology (ESMO) Gastrointestinal Cancers Congress in Munich, Germany. Dr. Pashtoon Kasi, the originator of this groundbreaking study,.
Is It Worth Investing in Agenus Inc (NASDAQ: AGEN) Right Now?
Moreover, the 36-month beta value for AGEN is 1.29. Analysts have varying opinions on the stock, with 1 analysts rating it as a “buy,” 2 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for AGEN is 19.94M and currently, short sellers hold a 11.24% of that float. On June 28, 2024, AGEN’s average trading volume was 822.47K shares.
AGEN’s Market Performance
AGEN stock saw an increase of 4.21% in the past week, with a monthly gain of 0.95% and a quarterly increase of 30.80%. The volatility ratio for the week is 7.00%, and the volatility levels for the last 30 days are 9.57% for Agenus Inc (AGEN). The simple moving average for the last 20 days is -2.79% for AGEN’s stock, with a simple moving average of 3.35% for the last 200 days.
Analysts’ Opinion of AGEN
Many brokerage firms have already submitted their reports for AGEN stocks, with Robert W. Baird repeating the rating for AGEN by listing it as a “Outperform.” The predicted price for AGEN in the upcoming period, according to Robert W. Baird is $8 based on the research report published on June 06, 2023 of the previous year 2023.
Robert W. Baird, on the other hand, stated in their research note that they expect to see AGEN reach a price target of $80, previously predicting the price at $60. The rating they have provided for AGEN stocks is “Outperform” according to the report published on June 06th, 2023.
H.C. Wainwright gave a rating of “Buy” to AGEN, setting the target price at $8 in the report published on February 28th of the previous year.
AGEN Trading at 19.70% from the 50-Day Moving Average
After a stumble in the market that brought AGEN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -60.69% of loss for the given period.
Volatility was left at 9.57%, however, over the last 30 days, the volatility rate increased by 7.00%, as shares surge +0.60% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +181.48% upper at present.
During the last 5 trading sessions, AGEN rose by +4.40%, which changed the moving average for the period of 200-days by -40.62% in comparison to the 20-day moving average, which settled at $15.61. In addition, Agenus Inc saw -8.36% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at AGEN starting from ARMEN GARO H, who purchase 500,000 shares at the price of $0.65 back on Feb 15 ’24. After this action, ARMEN GARO H now owns 625,969 shares of Agenus Inc, valued at $324,050 using the latest closing price.
WIINBERG ULF, the Director of Agenus Inc, purchase 25,000 shares at $0.76 during a trade that took place back on Nov 15 ’23, which means that WIINBERG ULF is holding 124,063 shares at $19,000 based on the most recent closing price.
Stock Fundamentals for AGEN
Current profitability levels for the company are sitting at:
- -0.86 for the present operating margin
- 0.26 for the gross margin
The net margin for Agenus Inc stands at -1.51. The total capital return value is set at -248.2.
Based on Agenus Inc (AGEN), the company’s capital structure generated 3.38 points at debt to capital in total, while cash flow to debt ratio is standing at -0.66. The debt to equity ratio resting at -1.42. The interest coverage ratio of the stock is -1.23.
Currently, EBITDA for the company is -146.52 million with net debt to EBITDA at -2.41. When we switch over and look at the enterprise to sales, we see a ratio of 3.79. The receivables turnover for the company is 339.11for trailing twelve months and the total asset turnover is 0.63. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.24.
Conclusion
To wrap up, the performance of Agenus Inc (AGEN) has been mixed in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
